SENESCORE
LIVE

Serial Number

98638764

Owner

Ponce Therapeutics, Inc.

Attorney

Jared L. DuJack

Filing Date

Jul 9, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SENESCORE Trademark

Serial Number: 98638764

SENESCORE is a trademark filed by Ponce Therapeutics, Inc. on July 9, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Ponce Therapeutics, Inc. (5 trademarks)

9511 Collins Avenue #1403
Surfside, FL 33154

Entity Type: 03

SENOTHERAPEUTIX, INC.

9511 COLLINS AVENUE, #1403
SURFSIDE, FL 33154

Entity Type: 03

Trademark Details

Filing Date

July 9, 2024

Registration Date

Not Registered

Goods & Services

Anti-aging therapy in the nature of treatment of age-related conditions; Anti-aging services, namely, treatment of age-related conditions; Anti-aging therapy in the nature of treatment to improve longevity; Medical services; Medical services, namely, anti-aging services in the nature of treatment of age-related conditions; Medical services, namely, treatment of age-related disorders; Medical services in the nature of treatment to improve longevity; Medical advisory services; Medical advisory services in the field of anti-aging; Medical advisory services in the field of prevention and treatment of age-related disorders; Medical testing services; Medical testing services in the field of anti-aging; Medical testing services in the field of prevention and treatment of age-related disorders; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Medical testing services in the nature of performing biopsies in the field of senescent cells; Medical testing services in the nature of performing biopsies in the field of disorders related to biologic age; Medical testing services in the nature of performing biopsies in the field of biological age scoring; Medical testing services in the nature of performing biopsies in the field of determining a number or percentage of senescent cells; Medical laboratory services relating to the treatment of persons; Medical laboratory services relating to the treatment of persons related to biologic age; Medical laboratory services relating to the treatment of persons related to biological age scoring; Medical laboratory services relating to the treatment of persons related to determining a number or percentage of senescent cells; Non-invasive medical testing; Non-invasive medical testing related to biologic age; Non-invasive medical testing related to biological age scoring; Non-invasive testing related to determining a number or percentage of senescent cells

Medical research services; Medical research services in the field of longevity and anti-aging services; Medical research services in the field of prevention and treatment of age-related disorders; Biological research and analysis, namely, biologic age scoring; Biological research and analysis, namely, statistical scoring to determine a biologic age score of a patient; Biological research laboratory services; Biological research laboratory services related to biologic age; Biological research laboratory services related to biological age scoring; Biological research laboratory services related to determining a number or percentage of senescent cells

Filing History

NOTIFICATION OF FINAL REFUSAL EMAILED
May 1, 2026 GNFN
FINAL REFUSAL E-MAILED
May 1, 2026 GNFR
FINAL REFUSAL WRITTEN
May 1, 2026 CNFR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 11, 2025 ASGN
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 4, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 8, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 8, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 8, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 1, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 31, 2025 NWOS
NEW APPLICATION ENTERED
Jul 9, 2024 NWAP